《大行報告》美銀證券上調信行(00998.HK)目標價至4.96元 評級「跑輸大市」
美銀證券發表研究報告指出,中信銀行(00998.HK)去年純利按年增長13.6%至556億元人民幣,與公司早前指引一致;撥備前利潤按年僅增長0.8%,較該行預期輕微低0.8%;股本回報率按年回升0.6個百分點,至10.8%;普通股權一級資本比率維持在8.85%的緊張水平。派息比率上升1個百分點至28%,收益率接近10.8%。
該行將信行2022至2023財年的盈利預測上調5%至6%,目標價由4.75元上調至4.96元,維持對其「跑輸大市」評級,認為其核心盈利增長平淡無奇,流動性和資本緊張。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.